Hannah O'Neill

h-index

Research activity per year

Fingerprint

Dive into the research topics where Hannah O'Neill is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Article

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence for regulatory science and innovation in pharmacogenomics (CERSI-PGx)
Dello Russo, C., Frater, I., Kuruvilla, R., Lip, S., O'Neill, H., Burke, K., Chaplin, V., Doney, A. S. F., Elyas, S., Greaves, N., Harding, S., Hargroves, D., Hayward, J., Hughes, D. A., Hughes, T. A. T., Kondapally, S., Mok, P., Peace, A., Rafi, I. & Ray, S. & 3 others, Stinton, V., Venetucci, L. & Pirmohamed, M. (Lead / Corresponding author), 3 Dec 2025, (E-pub ahead of print) In: British Journal of Clinical Pharmacology.
Research output: Contribution to journal › Article › peer-review

Open Access
File
1 Citation (Scopus)

O'Neill, Hannah

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence for regulatory science and innovation in pharmacogenomics (CERSI-PGx)

O'Neill, Hannah

Fingerprint

Collaborations and top research areas from the last five years

Research output

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence for regulatory science and innovation in pharmacogenomics (CERSI-PGx)